We are live on ! Find out more
RCI

Ridgeback Capital Investments Portfolio holdings

AUM $560K
This Fund
S&P 500
This Quarter Est. Return
+14.39%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.3M
AUM Growth
–
Cap. Flow
+$83.7M
Cap. Flow %
100.37%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$60.8M
2
AFMD
Affimed
AFMD
+$22.6M
3
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$291K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
1
Bicycle Therapeutics
BCYC
$269M
$67M 80.44%
+2,264,801
New +$60.8M
AFMD
2
DELISTED
Affimed
AFMD
$16M 19.17%
+1,288,261
New +$22.6M
FSTX
3
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$332K 0.4%
+52,509
New +$291K

Similar funds

LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
ZIMP
Zimmermann Investment Management & Planning New Cumberland, Pennsylvania $2.27M AUM 29.81% 1-Year Est. Return
XS
XR Securities Chicago, Illinois $5.35M AUM 26.1% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return
AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Ridgeback Capital Investments's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Ridgeback Capital Investments, which disclosed 3 positions worth $83.3M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Bicycle Therapeutics: 2,264,801 shares worth $67M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ridgeback Capital Investments's largest Q4 2022 buy was Bicycle Therapeutics: 2,264,801 shares worth $67M.
  • Ridgeback Capital Investments's ten largest holdings make up 100% of its $83.3M portfolio in Q4 2022.
  • Ridgeback Capital Investments disclosed 3 positions in Q4 2022, its first 13F filing on record.

Based on Ridgeback Capital Investments's 13F filing for Q4 2022, filed 14 Feb 2023.